China Pharma Holdings Inc - Asset Resilience Ratio

Latest as of September 2025: 0.17%

China Pharma Holdings Inc (CPHI) has an Asset Resilience Ratio of 0.17% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read CPHI total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

$26.70K

Cash + Short-term Investments

Total Assets

$15.98 Million

All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2011–2023)

This chart shows how China Pharma Holdings Inc's Asset Resilience Ratio has changed over time. See China Pharma Holdings Inc net assets for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down China Pharma Holdings Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see CPHI company net worth.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	$0.00	0%
Short-term Investments	$26.70K	0.17%
Total Liquid Assets	$26.70K	0.17%

Asset Resilience Insights

Limited Liquidity: China Pharma Holdings Inc maintains only 0.17% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

China Pharma Holdings Inc Industry Peers by Asset Resilience Ratio

Compare China Pharma Holdings Inc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Jiangsu Hengrui Medicine Co Ltd SHG:600276	Drug Manufacturers - Specialty & Generic	0.16%
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	Drug Manufacturers - Specialty & Generic	4.94%
Hubei Jumpcan Pharmaceutical Co Ltd SHG:600566	Drug Manufacturers - Specialty & Generic	35.10%
Tianjin Zhongxin Pharmaceutical Group Corp Ltd SHG:600329	Drug Manufacturers - Specialty & Generic	5.92%
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt F:RIG2	Drug Manufacturers - Specialty & Generic	0.20%
Guangdong Zhongsheng Pharmaceutical Co Ltd SHE:002317	Drug Manufacturers - Specialty & Generic	6.62%
Shanghai Yizhong Pharmaceutical Co Ltd SHG:688091	Drug Manufacturers - Specialty & Generic	26.36%
Shenzhen Chipscreen Biosciences Co SHG:688321	Drug Manufacturers - Specialty & Generic	5.10%

Annual Asset Resilience Ratio for China Pharma Holdings Inc (2011–2023)

The table below shows the annual Asset Resilience Ratio data for China Pharma Holdings Inc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2023-12-31	0.40%	$65.92K	$16.47 Million	+0.32pp
2022-12-31	0.08%	$13.78K	$17.78 Million	-0.33pp
2021-12-31	0.40%	$91.36K	$22.65 Million	+0.15pp
2020-12-31	0.25%	$53.74K	$21.12 Million	+0.05pp
2019-12-31	0.21%	$45.76K	$22.24 Million	+0.16pp
2018-12-31	0.05%	$20.58K	$45.38 Million	-0.02pp
2017-12-31	0.07%	$39.87K	$59.95 Million	--
2016-12-31	0.00%	$0.00	$78.52 Million	--
2015-12-31	0.00%	$0.00	$97.22 Million	--
2014-12-31	0.35%	$458.00K	$132.08 Million	+0.13pp
2013-12-31	0.21%	$336.00K	$157.61 Million	+0.15pp
2012-12-31	0.06%	$102.00K	$163.24 Million	+0.01pp
2011-12-31	0.05%	$84.00K	$156.39 Million	--

pp = percentage points

About China Pharma Holdings Inc

NYSE MKT:CPHI USA Drug Manufacturers - Specialty & Generic

Market Cap

$2.32 Million

Market Cap Rank

#29738 Global

#5907 in USA

Share Price

$0.71

Change (1 day)

-0.99%

52-Week Range

$0.52 - $2.22

All Time High

$64.00